Press Release Archive
-
TYLENOL® SMILING IT FORWARD™ Celebrates “Feel Better” Smiles To Benefit Children’s Health FundTYLENOL® Partners with Pediatrician Tanya Altmann, MD and Mom Central to Help Moms by Giving Them Tips for Managing Childhood Milestones to Reveal Those Feel Better Smiles
-
U.S. FDA Approves INVOKAMET™ (canagliflozin/metformin HCl) for the Treatment of Adults with Type 2 DiabetesIn Phase 3 studies, INVOKANA® plus metformin lowered blood sugar and reduced secondary endpoints of body weight and systolic blood pressure to a greater degree than metformin alone
-
Janssen Launches Online Healthy Minds Video SeriesPromotes Knowledge of Brain Disorders and Encourages Anti-Stigma Efforts
-
Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen’s Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis CStudy evaluated interferon-free combination in treatment-naïve and prior null-responder patients with all stages of liver fibrosis, including cirrhosis
-
IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17pApproval based on Phase 3 RESONATE data with statistically significant improvements in progression-free and overall survival
-
Janssen Receives Positive CHMP Opinion Recommending IMBRUVICA™ for use in the Treatment of Two Forms of Blood Cancer
-
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014
-
Johnson & Johnson Announces $5 Billion Share Repurchase Program
-
Johnson & Johnson Reports 2014 Second-Quarter ResultsSales of $19.5 Billion increased 9.1% Versus 2013 Second Quarter; Second-Quarter EPS was $1.51 Excluding Special Items, 2014 Second-Quarter EPS of $1.66 increased 12.2%*
-
Janssen Pharmaceuticals Seeks Expanded Label for Once-Monthly INVEGA® SUSTENNA® (paliperidone palmitate) to Show Delayed Time to Relapse Compared to Daily Oral Schizophrenia TherapiesSubmission based on first head-to-head study vs. oral treatments in real world context